Neimeth International Pharmaceuticals Plc has reported a 49% increase in profit after tax for the first quarter of 2025, reaching ₦115.76 million compared to ₦77.65 million in Q1 2024. This growth reflects the company’s ongoing strategic initiatives and operational improvements. Key Financial Highlights: Turnover: Increased by 86% to ₦1.21 billion from ₦648.26 million. Gross [...]
Related Articles
Don't miss out on breaking stories and in-depth articles.